The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

Katy M.E. Turner, Sharon Hutchinson, Peter Vickerman, Vivian Hope, Noel Craine, Norah Palmateer, Margaret May, Avril Taylor, Daniela De Angelis, Sheila Cameron, John Parry, Margaret Lyons, David Goldberg, Elizabeth Allen, Matthew Hickman

Research output: Contribution to journal › Article

Abstract

The aim of this study was to investigate whether opiate substitution therapy (OST) and needle and syringe programmes (NSP) can reduce hepatitis C virus (HCV) transmission among injecting drug users (IDUs). Study design consisted of Meta-analysis and pooled analysis, with logistic regression allowing adjustment for gender, injecting duration, crack injecting and homelessness.
Original languageEnglish
Pages (from-to)1978-1988
Number of pages11
JournalAddiction
Volume106
Issue number11
Early online date24 Aug 2011
DOIs
Publication statusPublished - Nov 2011

Keywords

  • opiate substitution therapy
  • needle and syringe programmes
  • hepatitis C
  • virus transmission

Documents and Links

Fingerprint Dive into the research topics of 'The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence'. Together they form a unique fingerprint.

    • Cite this

    Turner, K. M. E., Hutchinson, S., Vickerman, P., Hope, V., Craine, N., Palmateer, N., May, M., Taylor, A., De Angelis, D., Cameron, S., Parry, J., Lyons, M., Goldberg, D., Allen, E., & Hickman, M. (2011). The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction, 106(11), 1978-1988. https://doi.org/10.1111/j.1360-0443.2011.03515.x